These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17176891)

  • 1. [Cryotherapy is useful and safe in the prevention of oral mucositis after high-dose melphalan (L-PAM)].
    Inagaki N; Ohue Y; Shigeta H; Tasaka T
    Rinsho Ketsueki; 2006 Nov; 47(11):1469-71. PubMed ID: 17176891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryotherapy for the prevention of high-dose melphalan-induced oral mucositis.
    Mori T; Aisa Y; Yamazaki R; Mihara A; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2006 Nov; 38(9):637-8. PubMed ID: 16953203
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of high dose L-PAM-induced mucositis by cryotherapy.
    Dumontet C; Sonnet A; Bastion Y; Salles G; Espinouse D; Coiffier B
    Bone Marrow Transplant; 1994 Sep; 14(3):492-4. PubMed ID: 7994283
    [No Abstract]   [Full Text] [Related]  

  • 4. The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation.
    Vokurka S; Bystricka E; Scudlova J; Mazur E; Visokaiova M; Vasilieva E; Brandejsova R; Chvojkova I; Vrabcova M; Vitkova J; Mjartanova D; Vodickova M; Bockova J; Streinerova K
    Eur J Oncol Nurs; 2011 Dec; 15(5):508-12. PubMed ID: 21310656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group.
    Gori E; Arpinati M; Bonifazi F; Errico A; Mega A; Alberani F; Sabbi V; Costazza G; Leanza S; Borrelli C; Berni M; Feraut C; Polato E; Altieri MC; Pirola E; Loddo MC; Banfi M; Barzetti L; Calza S; Brignoli C; Bandini G; De Vivo A; Bosi A; Baccarani M
    Bone Marrow Transplant; 2007 Mar; 39(6):347-52. PubMed ID: 17277790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
    Lilleby K; Garcia P; Gooley T; McDonnnell P; Taber R; Holmberg L; Maloney DG; Press OW; Bensinger W
    Bone Marrow Transplant; 2006 Jun; 37(11):1031-5. PubMed ID: 16633359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
    Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
    J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients.
    Aisa Y; Mori T; Kudo M; Yashima T; Kondo S; Yokoyama A; Ikeda Y; Okamoto S
    Support Care Cancer; 2005 Apr; 13(4):266-9. PubMed ID: 15668755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver.
    Vahrmeijer AL; van Dierendonck JH; Keizer HJ; Beijnen JH; Tollenaar RA; Pijl ME; Marinelli A; Kuppen PJ; van Bockel JH; Mulder GJ; van de Velde CJ
    Br J Cancer; 2000 May; 82(9):1539-46. PubMed ID: 10789721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
    McCann S; Schwenkglenks M; Bacon P; Einsele H; D'Addio A; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vorkurka S; Quinn B; Blijlevens N;
    Bone Marrow Transplant; 2009 Jan; 43(2):141-7. PubMed ID: 18776926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.
    Chen J; Seabrook J; Fulford A; Rajakumar I
    J Oncol Pharm Pract; 2017 Mar; 23(2):116-120. PubMed ID: 26684614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy: the effect of oral cryotherapy on the development of mucositis.
    Karagözoğlu S; Filiz Ulusoy M
    J Clin Nurs; 2005 Jul; 14(6):754-65. PubMed ID: 15946284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
    Batlle M; Morgades M; Vives S; Ferrà C; Oriol A; Sancho JM; Xicoy B; Moreno M; Magallón L; Ribera JM
    Eur J Haematol; 2014 Dec; 93(6):487-91. PubMed ID: 24889275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of high-dose melphalan-induced mucositis by cryotherapy.
    Tartarone A; Matera R; Romano G; Vigliotti ML; Di Renzo N
    Leuk Lymphoma; 2005 Apr; 46(4):633-4. PubMed ID: 16019498
    [No Abstract]   [Full Text] [Related]  

  • 15. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation.
    Ohbayashi Y; Imataki O; Ohnishi H; Iwasaki A; Ogawa T; Inagaki N; Shigeta H; Ohue Y; Tasaka T; Kitanaka A; Kubota Y; Tanaka T; Ishida T; Miyake M
    Ann Hematol; 2008 Oct; 87(10):837-45. PubMed ID: 18553082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan-induced oral mucositis during hematological stem-cell transplantation: a prospective clinical study.
    de Paula Eduardo F; Bezinelli LM; da Graça Lopes RM; Nascimento Sobrinho JJ; Hamerschlak N; Correa L
    Hematol Oncol; 2015 Sep; 33(3):152-8. PubMed ID: 24519448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil.
    Nikoletti S; Hyde S; Shaw T; Myers H; Kristjanson LJ
    J Clin Nurs; 2005 Jul; 14(6):750-3. PubMed ID: 15946283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of High-Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy Trial.
    Cho YK; Sborov DW; Lamprecht M; Li J; Wang J; Hade EM; Gao Y; Tackett K; Williams N; Benson DM; Efebera YA; Rosko AE; Devine SM; Poi M; Hofmeister CC; Phelps MA
    Clin Pharmacol Ther; 2017 Sep; 102(3):511-519. PubMed ID: 28160288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation].
    Imataki O; Aoyama T; Tamai Y; Kawakami K
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1633-6. PubMed ID: 17940379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palifermin for prevention of oral mucositis after haematopoietic stem cell transplantation- single centre experience.
    Rzepecki P; Sarosiek T; Barzal J; Oborska S; Nurzynski P; Wasko A; Szczylik C
    J BUON; 2007; 12(4):477-82. PubMed ID: 18067205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.